| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |